NCT00345410View on ClinicalTrials.gov

Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia

PHASE2CompletedINTERVENTIONAL

Enrollment

345

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

ObesityDyslipidemia

Interventions

DRUG

AVE1625 B

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY